Einhorn firm reports new stake in Intrexon 5:20 p.m. Nov. 14, 2013 - Bradley Hope
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Intrexon IPO prices at $16, top end of range 6:03 a.m. Aug. 8, 2013 - MarketWatch.com
Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape 9:25 a.m. Nov. 18, 2013 - Zacks.com
Tracking David Einhorn's Portfolio - Q3 2013 Update 4:58 a.m. Nov. 15, 2013 - Seeking Alpha
Einhorn's Greenlight Buys NVR, Intrexon, Sells Oaktree, Rite Aid 5:21 p.m. Nov. 14, 2013 - TheStreet.com
David Einhorn's New Stocks - TPX, XON, NVR 4:01 p.m. Nov. 14, 2013 - GuruFocus.com
10-Q: SYNTHETIC BIOLOGICS, INC. 1:13 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: FIBROCELL SCIENCE, INC. 8:36 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: INTREXON CORP 4:58 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
A Biotech Star’s Next Big Idea 1:30 p.m. Oct. 24, 2013 - streetauthority.com
The Hottest IPOs of 2013 4:43 a.m. Oct. 7, 2013 - 247WallSt.com
Oragenics, Intrexon Announce Deal to Develop Genetically Modified Probiotics, Intrexon Invests $3.9M in Oragenics 7:40 a.m. Oct. 1, 2013 - benzinga.com
Sun Pharma, Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases 5:06 a.m. Oct. 1, 2013 - benzinga.com
Seven Hot Summer IPOs Up 50% or More: Not All Created Equally 5:28 a.m. Sept. 20, 2013 - 247WallSt.com
10-Q: INTREXON CORP 5:05 a.m. Sept. 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
Intrexon: A Billionaire's Dream About The Future Of Biotech 3:07 p.m. Sept. 12, 2013 - Seeking Alpha
Top 10 Analyst Upgrades and Downgrades: Apache, Nokia, Verizon and More 6:46 a.m. Sept. 3, 2013 - 247WallSt.com
Pound For Pound, Are Biotechs Still Worth Their Salt? 4:12 p.m. Aug. 23, 2013 - Investors Business Daily
Weekly CEO Buys Highlight: XON, ARCP, FSFR, CNTY, RHP 8:09 p.m. Aug. 18, 2013 - GuruFocus.com
Big Oil Buying Biofuels Companies: Expect The Trend To Continue 11:15 a.m. Aug. 15, 2013 - Seeking Alpha
Soligenix: Kirk Seal Of Approval, And Government Contract Catalyst Imminent 3:39 p.m. Aug. 14, 2013 - Seeking Alpha
Intrexon: Successful Public Offering For A Potentially Revolutionary Company 10:05 a.m. Aug. 11, 2013 - Seeking Alpha
FDA Clearance, Management Changes, and Clinical Study Updates - Research Report on Illumina, Array, Oncolytics, Intrexon, and STERIS 8:00 a.m. Nov. 26, 2013 - PR Newswire
AquaBounty Cleared To Produce Salmon Eggs In Canada For Commercial Purposes 7:00 a.m. Nov. 25, 2013 - PR Newswire
Intrexon Appoints Executives to Expand European and Asian Markets, Accelerate Technology Platform Development 9:00 a.m. Nov. 18, 2013 - PR Newswire
Fibrocell Science Announces Third Quarter 2013 Financial Results 8:45 a.m. Nov. 14, 2013 - BusinessWire
Synthetic Biologics Reports Third Quarter 2013 Financial Results and Operational Update 7:00 a.m. Nov. 14, 2013 - PR Newswire
Public Offerings, Clinical Tests, and Financial Results- Research Report on InterMune, Emergent BioSolutions, ImmunoGen, Sequenom, and Intrexon 8:00 a.m. Nov. 13, 2013 - PR Newswire
Soligenix Reports Third Quarter 2013 Financial Results, and Highlights Recent Accomplishments 7:15 a.m. Nov. 12, 2013 - PR Newswire
Intrexon Announces Third Quarter Financial Results 4:35 p.m. Nov. 7, 2013 - PR Newswire
Oragenics Announces Breakthrough Antibiotic Analog Generation in Intrexon Collaboration 2:42 p.m. Oct. 31, 2013 - BusinessWire
Oragenics Announces Breakthrough Antibiotic Analog Generation in Intrexon Collaboration 8:00 a.m. Oct. 31, 2013 - BusinessWire
Fibrocell Science Honored with Partner in Progress Award from DEBRA of America 8:30 a.m. Oct. 25, 2013 - BusinessWire
Mesoblast, Intrexon and ZIOPHARM to Target Cancers 6:28 p.m. Oct. 23, 2013 - GlobeNewswire
ZIOPHARM Announces Third Quarter Financial Results and Updates Key Development Activities 4:01 p.m. Oct. 22, 2013 - GlobeNewswire
ZIOPHARM and Intrexon Announce Presentation of Data Highlighting Regulated Gene Expression System in Tumor-Homing Mesenchymal Stem Cells 12:30 p.m. Oct. 22, 2013 - GlobeNewswire
ZIOPHARM and Intrexon Announce Presentation of Data Highlighting Versatility of Novel Gene Expression and Control Technology 12:30 p.m. Oct. 21, 2013 - GlobeNewswire
Soligenix Announces Formation of International Melioidosis Scientific Advisory Board 7:15 a.m. Oct. 17, 2013 - PR Newswire
ZIOPHARM and Intrexon Announce Presentations at the 2013 AACR-NCI-EORTC International Conference 7:00 a.m. Oct. 17, 2013 - GlobeNewswire
Clinical Study Updates, Trial Enrollments, NDA Submissions, Partnerships, and Formation of New Subsidiaries - Research Report on BioMarin, Alnylam, Vertex, Illumina, and Intrexon 8:00 a.m. Oct. 7, 2013 - PR Newswire
Intrexon Establishes "Living Arts" Company, BioPop, to Create Consumer Products Inspired by Nature and Made Possible through Science 8:00 a.m. Oct. 2, 2013 - PR Newswire
Oragenics and Intrexon to Develop Genetically Modified Probiotics 9:35 a.m. Oct. 1, 2013 - PR Newswire